These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 15985826

  • 1. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
    Navon-Venezia S, Ben-Ami R, Carmeli Y.
    Curr Opin Infect Dis; 2005 Aug; 18(4):306-13. PubMed ID: 15985826
    [Abstract] [Full Text] [Related]

  • 2. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC, Resende JA, Bastos AN, De Andrade Bastos LQ, De Andrade Bastos VQ, Bastos RV, Diniz CG, Da Silva VL.
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [Abstract] [Full Text] [Related]

  • 3. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
    Potron A, Poirel L, Nordmann P.
    Int J Antimicrob Agents; 2015 Jun; 45(6):568-85. PubMed ID: 25857949
    [Abstract] [Full Text] [Related]

  • 4. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 5. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
    Zavascki AP, Carvalhaes CG, Picão RC, Gales AC.
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
    [Abstract] [Full Text] [Related]

  • 6. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
    Shanthi M, Sekar U.
    J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
    [Abstract] [Full Text] [Related]

  • 7. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
    Kunz AN, Brook I.
    Chemotherapy; 2010 Sep; 56(6):492-500. PubMed ID: 21099222
    [Abstract] [Full Text] [Related]

  • 8. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

  • 9. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Konai MM, Haldar J.
    ACS Infect Dis; 2020 Jan 10; 6(1):91-99. PubMed ID: 31646866
    [Abstract] [Full Text] [Related]

  • 10. Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America.
    Labarca JA, Salles MJ, Seas C, Guzmán-Blanco M.
    Crit Rev Microbiol; 2016 Jan 10; 42(2):276-92. PubMed ID: 25159043
    [Abstract] [Full Text] [Related]

  • 11. Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.
    Keen EF, Murray CK, Robinson BJ, Hospenthal DR, Co EM, Aldous WK.
    Infect Control Hosp Epidemiol; 2010 Jul 10; 31(7):728-32. PubMed ID: 20500036
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature.
    Falagas ME, Kopterides P.
    J Hosp Infect; 2006 Sep 10; 64(1):7-15. PubMed ID: 16822583
    [Abstract] [Full Text] [Related]

  • 13. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M, Rolain JM.
    Int J Antimicrob Agents; 2012 Feb 10; 39(2):105-14. PubMed ID: 22113193
    [Abstract] [Full Text] [Related]

  • 14. Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.
    Geisinger E, Isberg RR.
    J Infect Dis; 2017 Feb 15; 215(suppl_1):S9-S17. PubMed ID: 28375515
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M, Sharma A, Sen MK, Rani V, Gaind R, Suri JC.
    Microb Pathog; 2019 Mar 15; 128():75-81. PubMed ID: 30562602
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
    Mekonnen H, Seid A, Molla Fenta G, Gebrecherkos T.
    PLoS One; 2021 Mar 15; 16(11):e0257272. PubMed ID: 34780494
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and Molecular Characterization of New Delhi Metallo-Beta-Lactamases in Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii from India.
    Rahman M, Prasad KN, Gupta S, Singh S, Singh A, Pathak A, Gupta KK, Ahmad S, Gonzalez-Zorn B.
    Microb Drug Resist; 2018 Mar 15; 24(6):792-798. PubMed ID: 29058515
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.